Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Merck KGaA Opens $189 Million Nantong Pharma Plant; Plans $89 Million Life Science Center

publication date: Nov 4, 2016

Merck KGaA of Germany officially opened its new $189 million China pharmaceutical plant in Nantong and announced another $89 million investment in a nearby Life Science center. The Nantong facility will produce drugs for China's Essential Drug List while the new Life Science Center will manufacture high-purity inorganic salts, cell culture media products as well as ready-to-use media for drug discovery and production. Merck said the plants will help transform Merck from an importing company to a local China pharma. More details....

Stock Symbol: (XE: MRK)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital